Hologic Inc., In the Matter of

Last Updated:
In the Matter of Hologic Inc.
FTC Matter/File Number:


Enforcement Type:

Part 2 Consents

Case Summary

The Commission approved a final consent order to ensure the maintenance of competition in the market for prone stereotactic breast biopsy systems (SBBSs). The Commission had challenged this merger which was consummated in 2005. The order required the divestiture of all prone SBBS assets to Siemens, a company well-positioned to become a competitor in this market.